Itraconazole Focus Pharmaceuticals Ltd

Itraconazole, the active ingredient in Itraconazole Focus Ltd, is an azole antifungal presented as an oral formulation for systemic use. It treats a range of fungal infections in adults and children, including skin, nail and deep organ infections.

GNH USA supplies Itraconazole Focus Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Its distribution network ensures timely delivery across diverse regulatory environments.

Itraconazole is used to treat fungal infections affecting the skin, nails and internal organs. - Dermatophytosis: effective in clearing skin infections caused by dermatophyte fungi. - Onychomycosis: promotes regrowth of healthy nail tissue by eradicating nail‑plate fungal invasion. - Systemic mycoses (e.g., blastomycosis, histoplasmosis, coccidioidomycosis): provides systemic antifungal activity for deep‑seated infections.

Itraconazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea or vomiting - Abdominal pain or dyspepsia - Diarrhea - Headache - Rash or pruritus - Elevated liver enzymes (asymptomatic)

Serious or Rare Side Effects: - Hepatotoxicity with jaundice - Severe skin reactions such as Stevens‑Johnson syndrome - Cardiac failure or arrhythmias - Visual disturbances - Peripheral edema - Anaphylactic reactions

When prescribing itraconazole, clinicians should consider several safety precautions to minimize risk. - Liver function monitoring: assess baseline enzymes and repeat during therapy. - Drug‑interaction review: avoid concomitant use with strong CYP3A4 inhibitors or inducers. - Cardiac assessment: caution in patients with heart failure or arrhythmias. - Pregnancy and lactation: use only if potential benefit outweighs risk; discuss with obstetrician. - Patient counseling: advise on taking with food to enhance absorption and report any rash. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Itraconazole interacts with several medicines due to its effect on cytochrome P450 enzymes and transport proteins.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may cause toxic itraconazole levels. - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce efficacy. - Certain statins (e.g., simvastatin, lovastatin): increased risk of rhabdomyolysis. - Digoxin: elevated serum concentrations. - Sildenafil: heightened hypotensive effect.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): monitor INR for potential increase. - Anticonvulsants (phenytoin, phenobarbital): may lower itraconazole exposure. - HIV protease inhibitors (ritonavir): may alter plasma levels. - Calcium channel blockers (verapamil): possible additive cardiac effects. - Oral contraceptives: reduced effectiveness, advise backup method.